1.Treatment of concealed penis
Fazhi QI ; Yuedong SHI ; Jianying GU ; Xuejun ZHANG
Chinese Journal of Medical Aesthetics and Cosmetology 2001;0(03):-
Objective To introduce the clinical manifestations and treatment methods of concealed penis, which is relative rare in plastic surgery. Methods Vertical preputiotomy was performed. The hypoplastic tissuely was excised. After that, there was no prepuce redundant, so that no prepuce excision was needed. Results 7 patients were treated. All were satisfied with the results. Conclusion Concealed penis should be distinguished from phimosis. Circumcision should be avoided in concealed penis patient.
2.Skin-sparing Mastectomy and Immediate TRAM Breast Reconstruction
Fazhi QI ; Junxue CHEN ; Jianying GU ; Yuedong SHI ; Xuejun ZHANG ; Kunnan WU
Fudan University Journal of Medical Sciences 2000;27(6):488-491
Purpose To introduce our experience about the skin-sparing mastectomy and immediate breast reconstruction using transverse rectus abdominis myocutaneous flap(TRAM). Methods For early stage breast cancer,we preserved the breast skin,performed the subcutaneous glandular excision and axillary dissection,immediately reconstructed the breast using TRAM flap. Results 9 patients were treated by skin-sparing mastectomy and immediate TRAM breast reconstruction.The morphology of reconstructed breasts was excellent. Conclusions The skin-sparing mastectomy and immediate TRAM breast reconstruction is safe and effective for treating early stage breast cancer.The incision is relative small and more aesthestic.
3.Vertical reduction mammoplasty based on Würinger's horizontal septum
Jianying GU ; Yong ZHANG ; Zihao FENG ; Yanwen YANG ; Yuedong SHI ; Fazhi QI
Chinese Journal of Medical Aesthetics and Cosmetology 2018;24(1):24-27
Objective The vertical mammoplasty which improves the breast morphology and reduces the operative scar has become the first selection of breast reduction.However,the nipple-and-areola complex (NAC) had the risk of necrosis in those severe patients.In this report,we performed the vertical reduction mammoplasty based on Wu'ringer's horizontal septum to reduce the NAC necrosis possibility.Methods Typical Lejourmosque-dome design was performed.The inferior part of glandular tissue and the skin were excised.The NAC was elevated to normal position based on Wu'ringer's horizontal septum.The breast morphology was modified with vertical scar left.Results 79 patients were operated.4 patients had unilateral breast reduction.4 breasts had partial wound dehiscence.They were treated conservatively with topical dressing.No complete NAC necrosis occurred.Conclusions The vertical reduction mammoplasty based on Wu'ringer's horizontal septum is a safe and effective procedure.The NAC necrosis risk is reduced.This method deserves to be recommended.
4.Classification Tree Model Analysis on Risk Factors of Diabetic Kidney Disease to Progress to ESRD for CKD3-4 Stages Patients
Zhi-bo LIAO ; Xun LIU ; Cai-lian CHENG ; Cheng-gang SHI ; Shao-min LI ; Wen-bo ZHAO
Journal of Sun Yat-sen University(Medical Sciences) 2019;40(5):767-773
【Objective】To analyze the risk factors of progression to end-stage renal disease(ESRD)in patients with
diabetic kidney disease(DKD),and screen the high-risk population for early prevention.【Methods】The clinical data of
231 patients with diabetic nephropathy in our hospital were collected and followed up for 3 years. According to whether
ESRD occurred,they were divided into non-progressing ESRD group(133 cases)and ESRD group(98 cases). Classification
tree model was used to analyze the risk factors related to ESRD,and the high-risk population was screened by node gain
analysis.【Results】Four important explanatory variables were screened out by the classification tree model from the candi⁃
date variables related to early renal damage,including apolipoprotein B(ApoB),gender,diabetic retinopathy,systemic blood
pressure(SBP). ApoB level was an important factor for DKD progression. For DKD patients with the chronic kidney disease
(CKD)3~4 stageswith ApoB> 1.14 mmol/L,theprobabilityofprogression toESRDfor 3 yearswas 75.0 %,and ifat the same
time with diabetic retinopathy,the probability was 79.7 %.【Conclusion】The classification tree model can analyze the risk
factors of progression to ESRD in DKD patients effectively,to identify the characteristics of high-risk populations.
5.Effects of erianin on the apoptosis of ovarian granulosa cells in rats with polycystic ovary syndrome and its mechanism
Lina FANG ; Yanyi LI ; Chao DONG ; Lili XU ; Zhaosong SHI ; Yuedong LI ; Bo YANG ; Zaichao XU
China Pharmacy 2024;35(11):1339-1344
OBJECTIVE To investigate the effects of erianin (ERI) on the apoptosis of ovarian granulosa cells in rats with polycystic ovary syndrome (PCOS) and its mechanism. METHODS PCOS rat model was constructed by subcutaneous injection of dehydroepiandrosterone, and the successfully constructed rats were randomly divided into PCOS group, ERI low-dose, medium- dose and high-dose groups (10, 20, 40 mg/kg) and ERI high dose + verteporfin group (40 mg/kg ERI + 10 mg/kg verteporfin), with 10 rats in each group. Another 10 normal rats were selected as the normal group. Rats in each administration group were given corresponding dose of ERI and/or intraperitoneal injection of vitiporfin, and rats in the PCOS group and normal group were orally administered an equal volume of 1% dimethyl sulfoxide, once a day, for 6 consecutive weeks. After administration, the body weight, fasting blood glucose (FPG), serum levels of estradiol (E2), testosterone (T), follicle stimulating hormone (FSH) and luteinizing hormone (LH) were detected in each group; morphological changes in ovarian tissue were observed, and the apoptosis of ovarian tissue cells was analyzed. Apoptosis-associated proteins [B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), Caspase-3] and Hippo-YAP signaling pathway associated proteins [large tumor suppressor kinase 1 (LATS1), phosphorylated LATS1 (p-LATS1) and Yes associated protein (YAP), phosphorylated YAP (p-YAP), transcriptional co-activator with PDZ binding motif (TAZ)] were detected in ovarian tissue. RESULTS Compared with PCOS group, the ovarian polycystic characteristics of the ERI low-dose, medium-dose,and high-dose groups were reduced, the number of atretic follicles was reduced, and the granulosa cell layer was thickened; the body mass, FPG, T, LH, LH/FSH, the number of cystic follicles, cell apoptosis index, protein expressions of Bax, Caspase-3, p-LATS1 and p-YAP were greatly decreased (P<0.05); the number of corpus luteum, protein expressions of E2, Bcl-2, LATS1, YAP and TAZ were greatly increased (P<0.05). Compared with ERI high-dose group, the above indexes in ERI high-dose + vitiporfin group were inhibited (P<0.05). CONCLUSIONS ERI can promote the proliferation of ovarian granulosa cells and improve the level of sex hormones in PCOS rats, and its mechanism of action may be related to the inhibition of the Hippo-YAP signaling pathway.
6.Effects of erianin on the apoptosis of ovarian granulosa cells in rats with polycystic ovary syndrome and its mechanism
Lina FANG ; Yanyi LI ; Chao DONG ; Lili XU ; Zhaosong SHI ; Yuedong LI ; Bo YANG ; Zaichao XU
China Pharmacy 2024;35(11):1339-1344
OBJECTIVE To investigate the effects of erianin (ERI) on the apoptosis of ovarian granulosa cells in rats with polycystic ovary syndrome (PCOS) and its mechanism. METHODS PCOS rat model was constructed by subcutaneous injection of dehydroepiandrosterone, and the successfully constructed rats were randomly divided into PCOS group, ERI low-dose, medium- dose and high-dose groups (10, 20, 40 mg/kg) and ERI high dose + verteporfin group (40 mg/kg ERI + 10 mg/kg verteporfin), with 10 rats in each group. Another 10 normal rats were selected as the normal group. Rats in each administration group were given corresponding dose of ERI and/or intraperitoneal injection of vitiporfin, and rats in the PCOS group and normal group were orally administered an equal volume of 1% dimethyl sulfoxide, once a day, for 6 consecutive weeks. After administration, the body weight, fasting blood glucose (FPG), serum levels of estradiol (E2), testosterone (T), follicle stimulating hormone (FSH) and luteinizing hormone (LH) were detected in each group; morphological changes in ovarian tissue were observed, and the apoptosis of ovarian tissue cells was analyzed. Apoptosis-associated proteins [B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), Caspase-3] and Hippo-YAP signaling pathway associated proteins [large tumor suppressor kinase 1 (LATS1), phosphorylated LATS1 (p-LATS1) and Yes associated protein (YAP), phosphorylated YAP (p-YAP), transcriptional co-activator with PDZ binding motif (TAZ)] were detected in ovarian tissue. RESULTS Compared with PCOS group, the ovarian polycystic characteristics of the ERI low-dose, medium-dose,and high-dose groups were reduced, the number of atretic follicles was reduced, and the granulosa cell layer was thickened; the body mass, FPG, T, LH, LH/FSH, the number of cystic follicles, cell apoptosis index, protein expressions of Bax, Caspase-3, p-LATS1 and p-YAP were greatly decreased (P<0.05); the number of corpus luteum, protein expressions of E2, Bcl-2, LATS1, YAP and TAZ were greatly increased (P<0.05). Compared with ERI high-dose group, the above indexes in ERI high-dose + vitiporfin group were inhibited (P<0.05). CONCLUSIONS ERI can promote the proliferation of ovarian granulosa cells and improve the level of sex hormones in PCOS rats, and its mechanism of action may be related to the inhibition of the Hippo-YAP signaling pathway.
7.Evaluation of Clinical Efficacy of Shengmaisan Granules in Inhibiting Myocardial Fibrosis in Patients with Chronic Heart Failure with Qi-Yin Deficiency Syndrome Based on CMR
Yuedong YANG ; Maolin WANG ; Juan ZHAO ; Mingyu SHI ; Chenhan MAO ; Sujie ZHANG ; Hao ZHI ; Jianping SHEN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(23):89-97
ObjectiveTo evaluate the effect of Shengmaisan granules on myocardial fibrosis in chronic heart failure patients with Qi-Yin deficiency syndrome by cardiac magnetic resonance (CMR) imaging and serological indicators. MethodSixty-six chronic heart failure patients with Qi-Yin deficiency syndrome who visited the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine from October 2021 to January 2023 were selected. The patients were assigned into a control group (33 cases) and an observation group (33 cases) by the minimization random method. Both groups received standardized Western medicine treatment for heart failure. In addition, the control group was treated with placebo granules, and the observation group with Shengmaisan granules for a course of 6 months. The baseline data, clinical efficacy, TCM symptom scores, serological indicators [high-sensitivity C-reactive protein (hs-CRP), soluble growth stimulation expressed gene 2 protein (sST2), pro-collagen Ⅲ N-terminal peptide (PⅢNP), interleukin (IL)-6, IL-11, transforming growth factor-β1 (TGF-β1)], echocardiography [Left atrial diameter (LAD), left ventricular end systolic diameter (LVEDs), left ventricular end diastolic diameter (LVEDd)] and CMR indicators [left ventricular ejection fraction (LVEF), myocardial extracellular volume fraction (ECV), and longitudinal relaxation time (T1)] were compared between the two groups. ResultFinally, 31 patients in the control group and 30 patients in the observation group were included. There was no significant difference in baseline data or indicators between the two groups before treatment. Compared with those before treatment, the scores of TCM symptoms (shortness of breath, fatigue, palpitations, spontaneous or night sweats, thirst/dry throat, feverish feeling in palms and soles, and edema in lower limbs), total score of TCM symptoms, ECV, T1, inflammation/fibrosis indicators (hs-CRP, sST2, PⅢNP, IL-6, IL-11, and TGF-β1) in observation group decreased (P<0.05, P<0.01), and the scores of TCM symptoms (except feverish feeling in palms and soles), T1, and inflammation/fibrosis indicators in the control group decreased (P<0.05, P<0.01). After treatment, the observation group had lower scores of TCM symptoms (except feverish feeling in palms and soles and edema in lower limbs), ECV, T1, and inflammation/fibrosis indicators than the control group (P<0.05, P<0.01). After treatment, the total response rate in the observation group was 93.33% (28/30), which was higher than that (80.65%, 25/31) in the control group (Z=2.976, P<0.01). There was no significant difference in adverse reactions between the two groups during treatment. ConclusionFor patients with chronic heart failure with Qi-Yin deficiency syndrome, Shengmaisan Granules can alleviate the TCM symptoms, reduce inflammation, and inhibit myocardial fibrosis by regulating the TGF-β1/IL-11 signaling axis.